Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;13(3):184-190.
doi: 10.14740/jocmr4452. Epub 2021 Mar 19.

Declining Intensive Care Unit Mortality of COVID-19: A Multi-Center Study

Sohaib Roomi  1 , Syed Omar Shah  2 , Waqas Ullah  1 , Shan Ul Abedin  1 , Karyn Butler  3 , Kelly Schiers  4 , Benjamin Kohl  5 , Erika Yoo  6 , Matthew Vibbert  2 , Jack Jallo  2
Affiliations

Declining Intensive Care Unit Mortality of COVID-19: A Multi-Center Study

Sohaib Roomi et al. J Clin Med Res. 2021 Mar.

Abstract

Background: Coronavirus disease 2019 (COVID-19) mortality has waned significantly over time; however, factors contributing towards this reduction largely remain unidentified. The purpose of this study was to evaluate the trend in mortality at our large tertiary academic health system and factors contributing to this trend.

Methods: This is a retrospective cohort study of intensive care unit (ICU) patients diagnosed with COVID-19 between March and August 2020 admitted across 14 hospitals in the Philadelphia area. Collected data included demographics, comorbidities, admission risk of mortality score, laboratory values, medical interventions, survival outcomes, hospital and ICU length of stay (LOS) and discharge disposition. Chi-square (χ2) test, Fisher exact test, Cochran-Mantel-Haenszel method, multinomial logistic regression models, independent sample t-test, Mann-Whitney U test and one-way analysis of variance (ANOVA) were used.

Results: A total of 1,204 patients were included. Overall mortality was 39%. Mortality declined significantly from 46% in March to 14% in August 2020 (P < 0.05). The most common underlying comorbidities were hypertension (60.2%), diabetes mellitus (44.7%), dyslipidemia (31.6%) and congestive heart failure (14.7%). Hydroxychloroquine (HCQ) use was more commonly associated with the patients who died, while the use of remdesivir, tocilizumab, steroids and duration of these medications were not significantly different. Peak values of ferritin, lactate dehydrogenase (LDH), C-reactive protein (CRP) and D-dimer levels were significantly higher in patients who died (P < 0.05). The mean hospital LOS was significantly longer in the patients who survived compared to the patients who died (18 vs. 12, P < 0.05).

Conclusions: The mortality of patients admitted to our ICU system significantly decreased over time. Factors that may have contributed to this may be the result of a better understanding of COVID-19 pathophysiology and treatments. Further research is needed to elucidate the factors contributing to a reduction in the mortality rate for this patient population.

Keywords: COVID-19; Intensive care unit; Mortality; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest disclosed by any of the authors associated with this manuscript.

References

    1. Ison MG, Wolfe C, Boucher HW. Emergency use authorization of remdesivir: the need for a transparent distribution process. JAMA. 2020;323(23):2365–2366. doi: 10.1001/jama.2020.8863. - DOI - PubMed
    1. Recovery Collaborative Group. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L. et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693–704. doi: 10.1056/NEJMoa2021436. - DOI - PMC - PubMed
    1. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E. et al. Remdesivir for the treatment of COVID-19-final report. N Engl J Med. 383(19):1813–1826. doi: 10.1056/NEJMoa2007764. - DOI - PMC - PubMed
    1. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;323(18):1775–1776. doi: 10.1001/jama.2020.4683. - DOI - PubMed
    1. Auld S, Caridi-Scheible M, Blum JM, Robichaux CJ, Kraft CS, Jacob JT, Jabaley CS, ICU and ventilator mortality among critically ill adults with COVID-19. medRxiv. 2020. - DOI - PMC - PubMed

LinkOut - more resources